Skip to content
10-Q

Quarterly Report

ORAMED PHARMACEUTICALS INC. ORMP

0001213900-25-076668

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 41M sh
Shares Diluted Q2 2025 · Jun 30, 2025 42.61M sh
Shares Diluted Q2 2025 · Jun 30, 2025 42.88M sh
Shares Diluted Q2 2025 · Jun 30, 2024 41.59M sh
Shares Diluted Q2 2025 · Jun 30, 2024 41.43M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $371K
Capex Q2 2025 · Jun 30, 2025 $7K
Capex Q2 2025 · Jun 30, 2024 $2K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$7.05M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $600K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $15.8M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $54.42M
Stockholders Equity Q2 2025 · Jun 30, 2025 $154.53M
Stockholders Equity Q2 2025 · Dec 31, 2024 $146.27M
Current Liabilities Q2 2025 · Jun 30, 2025 $3.69M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.69M
Current Assets Q2 2025 · Jun 30, 2025 $99.03M
Current Assets Q2 2025 · Dec 31, 2024 $143.22M
Total Assets Q2 2025 · Jun 30, 2025 $161.68M
Total Assets Q2 2025 · Dec 31, 2024 $155.28M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.31
Eps Diluted Q2 2025 · Jun 30, 2025 $0.13
Eps Diluted Q2 2025 · Jun 30, 2024 $0.22
Eps Diluted Q2 2025 · Jun 30, 2024 $0.26
Eps Basic Q2 2025 · Jun 30, 2025 $0.32
Eps Basic Q2 2025 · Jun 30, 2025 $0.14
Eps Basic Q2 2025 · Jun 30, 2024 $0.22
Eps Basic Q2 2025 · Jun 30, 2024 $0.26
Sga Expense Q2 2025 · Jun 30, 2025 $1.46M
Sga Expense Q2 2025 · Jun 30, 2025 $3.76M
Sga Expense Q2 2025 · Jun 30, 2024 $1.69M
Sga Expense Q2 2025 · Jun 30, 2024 $3.48M
Rd Expense Q2 2025 · Jun 30, 2025 $1.03M
Rd Expense Q2 2025 · Jun 30, 2025 $3.24M
Rd Expense Q2 2025 · Jun 30, 2024 $1.44M
Rd Expense Q2 2025 · Jun 30, 2024 $2.62M
Net Income Q2 2025 · Jun 30, 2025 $13.29M
Net Income Q2 2025 · Jun 30, 2025 $5.65M
Net Income Q2 2025 · Jun 30, 2024 $9.21M
Net Income Q2 2025 · Jun 30, 2024 $10.75M
Operating Income Q2 2025 · Jun 30, 2025 −$2.49M
Operating Income Q2 2025 · Jun 30, 2025 −$6.99M
Operating Income Q2 2025 · Jun 30, 2024 −$3.14M
Operating Income Q2 2025 · Jun 30, 2024 −$6.1M
Gross Profit Q2 2025 · Jun 30, 2025 $13K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.99M
Revenue Q2 2025 · Jun 30, 2025 $2M